Home » Newsletters » BioWorld Science

BioWorld Science

June 12, 1998

View Archived Issues

Company Profile: Genaissance Pharmaceuticals

Sheffield Pharmaceuticals and Elan to form pulmonary drug delivery collaboration

Phytera and Chiron enter research collaboration

PEG-rHuMGDF protects against toxicity of chemo- and radiotherapy in mice

CS-834 and R-95867 profiled at recent scientific meeting in Japan

Protein Design Labs' human antihepatitis B antibody enters phase IIa

Harvard Scientific reveals topical MED treatment

Procter & Gamble reveals new series of metalloprotease inhibitors

Preparation and use of new MMP inhibitors from Warner-Lambert

Asahi Glass, Santen develop ophthalmic agents with good safety

Japanese companies team up to develop compounds for schizophrenia

Lidak updates shareholders at annual meeting

Nippon Shinyaku discovers new treatment for urinary incontinence

Potent squalene synthase inhibitors as cholesterol-lowering agents

DPP IV inhibitor potentiates insulinotropic effect of GLP-1 in animal model

MF-268 shows long-lasting antiamnesic efficacy in rats

Abarelix: a promising new treatment option for patients with prostate cancer

Encouraging preliminary results with Ampalex presented at annual psychiatric meeting

Pharmacopeia receives grant to further develop selective aspartyl protease inhibitors

Texas Biotechnology updates stockholders at annual meeting

Bayer seeks FDA approval for improved second-generation hemophilia A product

Columbia receives FDA approval to evaluate Chronodyne in phase II

Antex Pharma: new Antex subsidiary dedicated to innovative infectious disease products

Nippon Shoji to market modafinil in Japan

Cidofovir safe and effective in severe respiratory papillomatosis

CI-1011: 50 times more potent than cholestyramine in hypolipidemic/antiatherogenic effects

DuPont Merck seeks FDA approval for Sustiva

NeuroSearch begins phase I trial for cocaine addiction treatment

CART: a hypothalamic anorectic peptide associated with leptin and NPY

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....